Literature DB >> 19680810

Immunopathology on hepatocyte expression of HBV surface, core, and x antigens in chronic hepatitis B: clinical and virological correlation.

Chia-Ming Chu1, Wei-Chue Shyu, Yun-Fan Liaw.   

Abstract

PURPOSE: Hepatocyte expression of HBV surface, core, and x antigens (HBsAg, HBcAg and HBxAg), semi-quantitated by immunopathology, were correlated with clinical and virological data in 80 patients with chronic hepatitis B.
RESULTS: Seventy patients were HBsAg positive in cytoplasm, 61 were HBcAg positive, including 45 in both nucleus and cytoplasm and 16 in cytoplasm only, and 47 were HBxAg positive in cytoplasm. The detection rates for HBcAg increased while those for HBsAg and HBxAg decreased with HBV DNA levels. Positive HBcAg staining usually suggested the presence of HBV DNA levels >10(6) copies/ml. HBcAg, HBsAg, and HBxAg expressions showed no significant differences between patients with genotype B and C. Serum HBeAg and HBV DNA levels correlated positively with nuclear or cytoplasmic HBcAg expression but inversely with HBsAg expression. By multiple regression analysis, HBV DNA levels correlated significantly only with nuclear HBcAg expression. ALT levels and inflammatory grades correlated with cytoplasmic HBcAg expression. There was an inverse quantitative relationship between HBcAg and HBsAg expression. Furthermore, HBxAg expression correlated significantly with HBsAg expression as well as male gender.
CONCLUSIONS: With diminishing HBV DNA levels following HBeAg seroconversion, HBcAg expression decreased but HBsAg expression increased with a concomitant increase in HBxAg expression. Whether the finding that a significantly higher expression of HBxAg observed in males than females may account for the gender difference in long-term sequelae of chronic HBV infection needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680810     DOI: 10.1007/s10620-009-0895-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis.

Authors:  W L Wang; W T London; L Lega; M A Feitelson
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

2.  Expression of pre-S1, pre-S2, S and X peptides in relation to viral replication in livers with chronic hepatitis B.

Authors:  K Suzuki; T Uchida; T Shikata; M Moriyama; Y Arakawa; M Mizokami; F Mima
Journal:  Liver       Date:  1990-12

3.  Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline.

Authors:  Chia-Ming Chu; Yun-Fan Liaw
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

4.  Subcellular localisation of the X protein in HBV infected hepatocytes.

Authors:  J Hoare; F Henkler; J J Dowling; W Errington; R D Goldin; D Fish; M J McGarvey
Journal:  J Med Virol       Date:  2001-08       Impact factor: 2.327

Review 5.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

6.  Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody.

Authors:  J Pál; C Somogyi; A Szmolenszky A; G Szekeres; J Sípos; G Hegedüs; I Martzinovits; J Molnár; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

7.  Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis.

Authors:  C M Chu; Y F Liaw
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

8.  Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment.

Authors:  Resat Ozaras; Fehmi Tabak; Veysel Tahan; Recep Ozturk; Hakan Akin; Ali Mert; Hakan Senturk
Journal:  Dig Dis Sci       Date:  2008-04-12       Impact factor: 3.199

9.  Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B.

Authors:  C M Chu; C T Yeh; I S Sheen; Y F Liaw
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

10.  Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.

Authors:  J H Seo; K W Kim; S Murakami; B C Park
Journal:  J Korean Med Sci       Date:  1997-12       Impact factor: 2.153

View more
  3 in total

1.  Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.

Authors:  Parham Safaie; Mugilan Poongkunran; Ping-Ping Kuang; Asad Javaid; Carl Jacobs; Rebecca Pohlmann; Imad Nasser; Daryl T Y Lau
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

2.  Histopathological changes in the liver of tree shrew (Tupaia belangeri chinensis) persistently infected with hepatitis B virus.

Authors:  Ping Ruan; Chun Yang; Jianjia Su; Ji Cao; Chao Ou; Chengpiao Luo; Yanping Tang; Qi Wang; Fang Yang; Junlin Shi; Xiaoxu Lu; Linqun Zhu; Hong Qin; Wen Sun; Yuanzhi Lao; Yuan Li
Journal:  Virol J       Date:  2013-11-12       Impact factor: 4.099

3.  A Novel Hydrodynamic Injection Mouse Model of HBV Genotype C for the Study of HBV Biology and the Anti-Viral Activity of Lamivudine.

Authors:  Xiumei Li; Guangze Liu; Meijuan Chen; Yang Yang; Yong Xie; Xiangping Kong
Journal:  Hepat Mon       Date:  2016-02-27       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.